Original price was: $199.99.$129.99Current price is: $129.99.
Research Studies:
Blend Specification:
Out of stock
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
BPC-157 + TB-500 (20mg Blend) is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
BPC-157 + TB-500 (20mg Blend) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | BPC-157 (137525-51-0), TB-500 (77591-33-4) |
|---|---|
| Purity | ≥99% |
| Molecular Formula | BPC-157: C62H98N16O22, TB-500: C212H350N56O78S |
| Molecular Weight | BPC-157: 1419.56 g/mol, TB-500: 4963.49 g/mol |
| Applications | Tissue repair research, inflammation studies, muscle and tendon regeneration investigations. |
| Sequence | BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Ser-Gly-Phe-Pro-Leu-Pro-Ser-Lys-Met-Met-Val-Glu-Thr-Lys-Phe |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for 24 months at -20°C in lyophilized form. After reconstitution, store at 4°C for up to 2 weeks or -20°C for up to 6 months. |
| Appearance | White crystalline powder |
| Shipping Conditions | Shipped at room temperature. Upon receipt, store at -20°C |
| Regulatory/Compliance | Complies with research use only standards. Not for drug, household, or other uses. |
| Safety Information | Refer to MSDS; handle according to established laboratory safety procedures |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy BPC-157+TB-500 online should evaluate BPC-157+TB-500 as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how qualified research teams can evaluate the BPC-157+TB-500 20mg Blend for controlled research procurement through Pure Lab Peptides.
Researchers can buy BPC-157+TB-500 online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase “buy BPC-157+TB-500 online” is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the search query belongs to qualified researchers, laboratory buyers, research institutions, and technical procurement teams comparing RUO sourcing documentation before adding a material to controlled laboratory inventory.
Research procurement is not the same as consumer purchasing. A technical buyer should evaluate whether the supplier clearly presents the material as research-use-only, whether a batch-specific COA is available, whether the product identity is supported by analytical documentation, and whether lot-level traceability can be matched across the product label and supplier paperwork.
For a peptide blend, documentation review is especially important because the procurement file should address more than one component. A BPC-157+TB-500 research material should be evaluated for component naming, blend composition, product form, stated purity, analytical method references, lot records, and storage information. The supplier language should remain focused on laboratory research, compound characterization, documentation, and analytical review.
Researchers should also confirm that the supplier avoids personal-use positioning. RUO procurement language should not include instructions for preparation, administration, or outcome-based claims. The safe commercial intent is “buy BPC-157+TB-500 online for laboratory research,” with documentation and traceability as the focus.
BPC-157+TB-500 is best evaluated as a peptide blend research material. A peptide is a short chain of amino acids linked by peptide bonds, and public scientific definitions distinguish peptides from longer polypeptide and protein chains by chain length and molecular organization [1].
Public compound records identify BPC-157 as a peptide with the molecular formula C62H98N16O22, and database records list synonyms and identifiers used for compound indexing [2]. FDA Global Substance Registration System records identify BPC-157 by name and list the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val [3]. ChEMBL also indexes BPC-157 under CHEMBL4297358, supporting database-level compound identity review [4].
Public records identify TB-500 under PubChem CID 62707662 with the molecular formula C38H68N10O14 [5]. FDA GSRS records list TB-500 with UNII QHK6Z47GTG, which provides another public identifier for supplier-documentation review [6]. TB-500 is commonly discussed in relation to thymosin beta-4 fragments; PubChem and UniProt records for thymosin beta-4 support neutral research context around the broader beta-thymosin category [7][8].
A peer-reviewed characterization paper describes the N-terminal acetylated 17-23 fragment of thymosin beta-4 identified in TB-500, illustrating why component identity and analytical confirmation matter for this blend category [9]. Research literature related to cellular pathways should not be converted into product-use claims for RUO materials. Blend composition should be evaluated through documentation and identity review, not expected outcomes or use protocols.
Researchers search “buy BPC-157+TB-500 online” to locate research-use-only product information, not to obtain personal-use guidance. The procurement goal is to compare RUO product availability, BPC-157+TB-500 supplier documentation, product-page clarity, COA access, and analytical support before selecting a source for laboratory inventory.
Technical teams may also search buy BPC-157+TB-500 when comparing product form, stated fill size, component naming, purity documentation, and batch-specific records across suppliers. For a blend, the procurement review should determine whether the supplier identifies the material consistently as BPC-157+TB-500 20mg Blend, whether the label language matches the product page, and whether the COA aligns with the lot received.
Commercial search intent can be satisfied without making human-use claims. A research-focused product page should help qualified buyers answer practical documentation questions: What is the material called? Is it labeled RUO? Is a BPC-157+TB-500 COA available? Does the documentation support identity testing? Is the supplier transparent about purity and lot-level traceability?
When technical buyers evaluate sources to buy BPC-157+TB-500 online, quality signals should come from documentation rather than promotional claims. FDA RUO guidance for in vitro diagnostic products is not a peptide-vendor rulebook, but it illustrates a useful principle for procurement teams: RUO labeling should be separated from diagnostic or clinical positioning [10].
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the available batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data listed in the documentation | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids therapeutic, outcome-based, or personal-use claims | Supports research-use-only positioning |
BPC-157+TB-500 purity documentation should be reviewed with the same discipline used for other research peptide materials. FDA analytical-method guidance discusses documentation for identity, quality, purity, and related analytical attributes, while the FDA-adopted ICH Q2(R2) and Q14 guidances describe general principles for analytical validation and analytical procedure development [11][12][13].
For peptide materials, researchers commonly review HPLC data, LC-MS data, mass spectrometry information, chromatographic traces, and lot-level COA fields when those items are included in supplier documentation. HPLC is widely used in peptide analysis and purification, and peer-reviewed analytical literature discusses peptide peak purity, structurally related peptide impurities, and synthetic-peptide impurity profiling by chromatographic and mass-spectrometric methods [14][15][16][17].
A complete documentation review should include compound name, product display name, lot number, test date, purity percentage, testing method, identity confirmation, component naming, molecular weight when documented, sequence when relevant, product form, and storage information. A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together.
COA records should be handled as part of a laboratory documentation package. NIST reference-material resources describe COAs as documents associated with certified chemical-property values, and ISO/IEC 17025 is a recognized framework for competent testing and calibration laboratories [18][19]. Researchers should review the product page and batch-specific documentation before adding any BPC-157+TB-500 research-use-only material to internal records.
Published literature should be treated as scientific context, not as product-use guidance. BPC-157 appears in database records, review literature, and preclinical research discussions, while TB-500 appears in synthesis, characterization, and analytical-method literature. The existence of published research does not establish a product claim for a research-use-only material.
Recent review literature discusses BPC-157 as a pentadecapeptide and summarizes research areas outside the scope of RUO procurement [20]. Earlier peer-reviewed literature also discusses BPC-157 under the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val [21]. These publications should be cited only to support neutral identity and literature-context statements, not to promote product outcomes.
For TB-500 context, thymosin beta-4 literature describes actin-binding-site characterization, and analytical publications describe LC-MS approaches for peptide detection and characterization [22][23]. Review literature on synthetic peptides in analytical control environments also shows why authentic standards, chromatographic methods, and mass-spectrometric confirmation matter for peptide research documentation [24].
Published clinical literature should not be interpreted as use guidance for RUO materials. Research literature related to cellular pathways should not be converted into product-use claims for RUO materials. For this blend category, the compliant procurement question is whether the material is clearly identified, documented, traceable, and labeled for research use only.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, synonyms, and component classification | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | Peptide-fragment literature, beta-thymosin context, and model-specific research areas | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, component confirmation, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “BPC-157+TB-500 is discussed in published research related to peptide identity, blend composition, and analytical characterization.” | Describes literature context without making a product claim | “BPC-157+TB-500 helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy BPC-157+TB-500 for results.” |
| “Pure Lab Peptides supplies BPC-157+TB-500 as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies BPC-157+TB-500 for therapy.” |
| “The phrase buy BPC-157+TB-500 online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy BPC-157+TB-500 online for personal use.” |
| “Blend composition should be evaluated through documentation and identity review.” | Supports procurement review without implying combined outcomes | “This blend should be selected for combined effects.” |
Pure Lab Peptides presents BPC-157+TB-500 20mg Blend as a research-use-only material. The product is supplied as lyophilized powder with a stated ≥99% purity claim, and a batch-specific COA is available for documentation review. Qualified researchers should review the COA, product-page details, storage and handling documentation, and lot-level traceability before procurement.
Review the Pure Lab Peptides BPC-157+TB-500 research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation. The broader research peptide collection can also help technical buyers compare product categories while keeping procurement language focused on laboratory documentation.
For a BPC-157+TB-500 research-use-only procurement file, the most important supplier signals are transparent labeling, BPC-157+TB-500 identity testing references, BPC-157+TB-500 supplier documentation, lot number consistency, product form clarity, and an available BPC-157+TB-500 COA. Supplier transparency should support research documentation, not personal-use positioning.
Buy BPC-157+TB-500 online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published literature can help researchers understand compound identity, component category, and analytical context. It should not be converted into product-use guidance for a BPC-157+TB-500 research-use-only material. Literature context and procurement documentation are separate review categories.
A stated purity percentage is useful, but it is not the full identity file. Researchers should evaluate the COA, compound name, lot number, component information, analytical method, chromatographic or mass information when documented, product form, and storage information together.
Batch specificity matters because laboratory records should match the material actually received. A BPC-157+TB-500 COA should be reviewed alongside the product label and lot number so the procurement file supports traceability and internal documentation.
RUO labeling does not support human or animal consumption. It indicates that the material is intended for controlled laboratory research settings. Researchers should confirm that the supplier language remains consistent with RUO positioning across product pages, labels, and documentation.
Supplier statements are not a substitute for BPC-157+TB-500 purity documentation, identity testing, and batch-specific records. Technical procurement teams should prioritize documentation they can file, review, and match to the lot received.
Researchers can buy BPC-157+TB-500 online for laboratory research by reviewing RUO suppliers that provide clear labeling, product details, available batch-specific COAs, purity documentation, identity information, and lot-level traceability. Pure Lab Peptides provides a BPC-157+TB-500 20mg Blend product page for qualified laboratory procurement review.
Before buying BPC-157+TB-500 online, researchers should check RUO labeling, the available batch-specific COA, product form, purity claim, identity documentation, lot number consistency, storage information, and supplier language. The supplier should frame the material as a laboratory research compound, not a personal-use product.
A COA matters when buying BPC-157+TB-500 because it helps researchers document the batch being procured. A useful COA review considers the compound name, lot number, analytical method, purity data, identity support, test date, and consistency with the product label and product page.
BPC-157+TB-500 is not intended for human or animal consumption in this research procurement context. It is discussed here as a research-use-only material for qualified laboratories. This article does not provide preparation, administration, medical, veterinary, or personal-use guidance.
Research use only means BPC-157+TB-500 should be evaluated as a laboratory material for controlled research settings. Procurement review should focus on labeling, documentation, COA availability, purity, identity testing, storage information, supplier transparency, and lot traceability.
Published literature about BPC-157, TB-500, thymosin beta-4 fragments, and peptide analytical methods should be interpreted as scientific context. It should not be treated as product-use guidance for RUO materials. Research teams should separate literature review from procurement documentation and supplier evaluation.
Qualified researchers evaluating BPC-157+TB-500 should review product labeling, COA status, identity documentation, storage information, and supplier transparency. For research teams comparing suppliers, prioritize COA availability, transparent RUO labeling, BPC-157+TB-500 purity documentation, and lot-level traceability.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.